These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31063714)

  • 1. In vitro and computational studies showed that perezone inhibits PARP-1 and induces changes in the redox state of K562 cells.
    Hernández-Rodríguez M; Mendoza Sánchez PI; Macias Perez ME; Rosales Cruz E; Mera Jiménez E; Nicolás Vázquez MI; Miranda Ruvalcaba R
    Arch Biochem Biophys; 2019 Aug; 671():225-234. PubMed ID: 31063714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and computational studies of natural products related to perezone as anti-neoplastic agents.
    Hernández-Rodríguez M; Mendoza Sánchez PI; Macías Perez ME; Cruz ER; Jiménez EM; Aceves-Hernández JM; Nicolás-Vázquez MI; Ruvalcaba RM
    Biochimie; 2020; 171-172():158-169. PubMed ID: 32145350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of Two New Sulfur Derivatives of Perezone: In Silico Study Simulation Targeting PARP-1 and In Vitro Study Validation Using Cancer Cell Lines.
    Rubiales-Martínez A; Martínez J; Mera-Jiménez E; Pérez-Flores J; Téllez-Isaías G; Miranda Ruvalcaba R; Hernández-Rodríguez M; Mancilla Percino T; Macías Pérez ME; Nicolás-Vázquez MI
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro and Computational Studies of Perezone and Perezone Angelate as Potential Anti-Glioblastoma Multiforme Agents.
    Hernández-Rodríguez M; Mendoza Sánchez PI; Martínez J; Macías Pérez ME; Rosales Cruz E; Żołek T; Maciejewska D; Miranda Ruvalcaba R; Mera Jiménez E; Nicolás-Vázquez MI
    Molecules; 2022 Feb; 27(5):. PubMed ID: 35268667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel synthesized phthalazinone-based PARP-1 inhibitors with apoptosis inducing mechanism in lung cancer.
    Almahli H; Hadchity E; Jaballah MY; Daher R; Ghabbour HA; Kabil MM; Al-Shakliah NS; Eldehna WM
    Bioorg Chem; 2018 Apr; 77():443-456. PubMed ID: 29453076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking and Biological Evaluation for Identification of Potential Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors.
    Zhou Y; Tang S; Chen T; Niu MM
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31766720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic components from the leaves of Erythrophleum fordii induce human acute leukemia cell apoptosis through caspase 3 activation and PARP cleavage.
    Vo PHT; Nguyen TDT; Tran HT; Nguyen YN; Doan MT; Nguyen PH; Lien GTK; To DC; Tran MH
    Bioorg Med Chem Lett; 2021 Jan; 31():127673. PubMed ID: 33161122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 2-(1-(3-(4-Chloroxyphenyl)-3-oxo- propyl)pyrrolidine-3-yl)-1
    Min R; Wu W; Wang M; Tang L; Chen D; Zhao H; Zhang C; Jiang Y
    Molecules; 2019 May; 24(10):. PubMed ID: 31108884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising anti- cervical carcinoma and inflammatory agent, Resveratrol targets poly (ADP-ribose) polymerase 1 (PARP-1) induced premature ovarian failure with a potent enzymatic modulatory activity.
    Alharbi H; Alshehri AS; Ahmad M; Guo WW
    J Reprod Immunol; 2021 Apr; 144():103272. PubMed ID: 33465522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer.
    Fu L; Wang S; Wang X; Wang P; Zheng Y; Yao D; Guo M; Zhang L; Ouyang L
    Sci Rep; 2016 Dec; 6(1):3. PubMed ID: 28442756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.
    Okuda A; Kurokawa S; Takehashi M; Maeda A; Fukuda K; Kubo Y; Nogusa H; Takatani-Nakase T; Okuda S; Ueda K; Tanaka S
    BMC Neurosci; 2017 Jan; 18(1):14. PubMed ID: 28095779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
    Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
    J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors.
    Chadha N; Jaggi AS; Silakari O
    Mol Divers; 2017 Aug; 21(3):655-660. PubMed ID: 28653128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel PARP-1 inhibitors based on pyridopyridazinone scaffold.
    Elmasry GF; Aly EE; Awadallah FM; El-Moghazy SM
    Bioorg Chem; 2019 Jun; 87():655-666. PubMed ID: 30952061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells.
    Marijon H; Lee DH; Ding L; Sun H; Gery S; de Gramont A; Koeffler HP
    Biomed Pharmacother; 2018 Mar; 99():543-551. PubMed ID: 29902865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PARP inhibitor PJ-34 sensitizes cells to UVA-induced phototoxicity by a PARP independent mechanism.
    Lakatos P; Hegedűs C; Salazar Ayestarán N; Juarranz Á; Kövér KE; Szabó É; Virág L
    Mutat Res; 2016 Aug; 790():31-40. PubMed ID: 27427773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of anticancer drugs and PJ-34 (poly(ADP-ribose)polymerase-1 (PARP-1) inhibitor) on HL-60 and Jurkat cells.
    Stępnik M; Spryszyńska S; Gorzkiewicz A; Ferlińska M
    Adv Clin Exp Med; 2017; 26(3):379-385. PubMed ID: 28791810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials.
    Yuan B; Ye N; Song SS; Wang YT; Song Z; Chen HD; Chen CH; Huan XJ; Wang YQ; Su Y; Shen YY; Sun YM; Yang XY; Chen Y; Guo SY; Gan Y; Gao ZW; Chen XY; Ding J; He JX; Zhang A; Miao ZH
    Cancer Lett; 2017 Feb; 386():47-56. PubMed ID: 27847302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-NAD-Like poly(ADP-Ribose) Polymerase-1 Inhibitors effectively Eliminate Cancer in vivo.
    Thomas C; Ji Y; Lodhi N; Kotova E; Pinnola AD; Golovine K; Makhov P; Pechenkina K; Kolenko V; Tulin AV
    EBioMedicine; 2016 Nov; 13():90-98. PubMed ID: 27727003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.